Viewing Study NCT05379595


Ignite Creation Date: 2025-12-24 @ 1:48 PM
Ignite Modification Date: 2026-01-01 @ 10:59 PM
Study NCT ID: NCT05379595
Status: RECRUITING
Last Update Posted: 2025-12-19
First Post: 2022-05-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
Sponsor: Janssen Research & Development, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module